Issue 14, 2021

Towards the design of active pharmaceutical ingredients mineralizing readily in the environment

Abstract

Active pharmaceutical ingredients (APIs), their metabolites, and transformation products (TPs) occur globally in the environment. They pose a risk to both environmental and human health. These alarming circumstances highlight the strong need for efficient measures, which is also reflected in EU strategies on sustainable chemicals and on pharmaceuticals in the environment. The design of APIs for mineralization in the environment according to the concept Benign by Design (BbD) is a promising approach to tackle this challenge. However, its implementation into the industrial API discovery process has not been discussed yet. To stimulate such a discussion and to better understand the applicability and limitations of this approach, the generic API discovery process is reviewed, including procedure, principles, and paradigms based on publicly available information. In addition to the concept of BbD itself, workflow scenarios such as de novo design and re-design are presented to provide a better understanding of its feasibility. Bringing these aspects together, we conclude that the optimization phase within drug discovery seems to be the most appropriate place to implement environmental considerations. At this early stage, costs are low and the potential impact of design and structural variation on the outcome is high. We found that pharmacological parameters required for application are sometimes even in line with biodegradability in the environment, since the conditions in the human body and the environment differ. However, the effects of optimizing pharmacological parameters such as toxicity and stability on environmental biodegradability of APIs must be considered together with design rules for biodegradability. Understanding the feasibility of BbD can mitigate the concerns pointed out by stakeholders and encourage them to invest in research and development, as well as support pharmaceutical companies to be prepared for upcoming regulations, since the aforementioned EU strategies announce further political regulations. We found also that successful implementation of BbD depends on the availability of suitable tools and methods as well as on incentives for research and development within constructive collaboration of industry, academia, and authorities.

Graphical abstract: Towards the design of active pharmaceutical ingredients mineralizing readily in the environment

Article information

Article type
Perspective
Submitted
26 মার্চ 2021
Accepted
21 জুন 2021
First published
21 জুন 2021

Green Chem., 2021,23, 5006-5023

Towards the design of active pharmaceutical ingredients mineralizing readily in the environment

N. Puhlmann, R. Mols, O. Olsson, J. C. Slootweg and K. Kümmerer, Green Chem., 2021, 23, 5006 DOI: 10.1039/D1GC01048D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements